New research investigations have shown significant optimism regarding the drug gantenerumab, a biological agent aimed to target amyloid deposits from the cerebrum. While earlier attempts at amyloid-targeting https://mediajx.com/story28631495/gantenerumab-a-potential-new-therapy-for-alzheimer-s-dementia